Veterans’ RightsAn independent resource for veterans
← All decisions
Remanded (sent back)

The Veteran's hepatitis C and cirrhosis of the liver are both rated at their current levels, but he contends that they warrant higher ratings. The Board has remanded these issues for further development to obtain additional medical evidence and opinion.

The deciding factor: The Veteran's claims involve rating criteria for hepatitis C and cirrhosis of the liver, which have overlapping symptoms but different diagnostic codes.

Claimed conditions
hepatitis C, cirrhosis of the liver
How they argued it
Direct service connection
Exposure basis
None
Rating assigned
None in this decision
Decision date
June 13, 2018
Citation
18110906

This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 18110906.

What this means for you

A remand is not a loss. The Board sent the case back for more development — often a new exam or missing records — before making a final decision. Many remands later end in a grant, and the decision spells out exactly what the Board wanted to see.

What you can do next

Related decisions

Other Board decisions on a similar condition or argued the same way.

Free starter guide for your own claim

Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.

We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.

We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.

This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.